References
- Abdelmalek, M. F., and A. M. Diehl. 2007. Nonalcoholic fatty liver disease as a complication of insulin resistance. The Medical Clinics of North America 91 (6):1125–49. doi:https://doi.org/10.1016/j.mcna.2007.06.001.
- Almeda-Valdes, P., N. Aguilar-Olivos, M. Uribe, and N. Méndez-Sánchez. 2014. Common features of the metabolic syndrome and nonalcoholic fatty liver disease. Reviews on Recent Clinical Trials 9 (3):148–58. doi:https://doi.org/10.2174/1574887109666141216103908.
- Almeda-Valdes, P., A. Altamirano-Barrera, and N. Méndez-Sánchez. 2015. Insights in non-alcoholic fatty liver disease pathophysiology with lipidomic analyses. Annals of Hepatology 14 (4):567–9. doi:https://doi.org/10.1016/S1665-2681(19)31182-2.
- Araya, J., R. Rodrigo, L. A. Videla, L. Thielemann, M. Orellana, P. Pettinelli, and J. Poniachik. 2004. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clinical Science (London, England : 1979) 106 (6):635–43. doi:https://doi.org/10.1042/CS20030326.
- Arendt, B. M., D. W. Ma, B. Simons, S. A. Noureldin, G. Therapondos, M. Guindi, M. Sherman, and J. P. Allard. 2013. Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine. Applied Physiology, Nutrition, and Metabolism 38 (3):334–40. doi:https://doi.org/10.1139/apnm-2012-0261.
- Bradbury, M. W. 2006. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: Possible role in steatosis. American Journal of Physiology. Gastrointestinal and Liver Physiology 290 (2):G194–G198. doi:https://doi.org/10.1152/ajpgi.00413.2005.
- Brown, M. V., S. A. Compton, M. V. Milburn, K. A. Lawton, and B. Cheatham. 2013. Metabolomic signatures in lipid-loaded HepaRGs reveal pathways involved in steatotic progression. Obesity (Silver Spring, Md.) 21 (12):E561–E570. doi:https://doi.org/10.1002/oby.20440.
- Charlton, M. 2004. Nonalcoholic fatty liver disease: A review of current understanding and future impact. Clinical Gastroenterology and Hepatology: Hepatology 2 (12):1048–58. doi:https://doi.org/10.1016/S1542-3565(04)00440-9.
- Chaurasia, B., and S. A. Summers. 2015. Ceramides - Lipotoxic inducers of metabolic disorders. Trends in Endocrinology and Metabolism: TEM 26 (10):538–50. doi:https://doi.org/10.1016/j.tem.2015.07.006.
- Corey, K. E., J. Misdraji, G. Lou, and Z. Hui. 2014. Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile. Lipids in Health and Disease 13 (100): 1-4. doi: https://doi.org/10.1186/1476-511X-13-100.
- Deng, P., J. B. Hoffman, M. C. Petriello, C.-Y. Wang, X.-S. Li, M. P. Kraemer, A. J. Morris, and B. Hennig. 2020. Dietary inulin decreases circulating ceramides by suppressing neutral sphingomyelinase expression and activity in mice. Journal of Lipid Research 61 (1):45–53. doi:https://doi.org/10.1194/jlr.RA119000346.
- Farrell, G. C., and C. Z. Larter. 2006. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology (Baltimore, Md.) 43 (2 Suppl 1):S99–S112. doi:https://doi.org/10.1002/hep.20973.
- Feldstein, A. E., N. W. Werneburg, A. Canbay, M. E. Guicciardi, S. F. Bronk, R. Rydzewski, L. J. Burgart, and G. J. Gores. 2004. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology (Baltimore, Md.) 40 (1):185–94. doi:https://doi.org/10.1002/hep.20283.
- Feng, S., L. Gan, C. S. Yang, A. B. Liu, W. Lu, P. Shao, Z. Dai, P. Sun, and Z. Luo. 2018. Effects of stigmasterol and β-sitosterol on nonalcoholic fatty liver disease in a mouse model: A lipidomic analysis. Journal of Agricultural and Food Chemistry. 66 (13): 3417–3425. doi: https://doi.org/10.1021/acs.jafc.7b06146.
- García-Cañaveras, J. C., M. T. Donato, J. V. Castell, and A. Lahoz. 2011. A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations. Journal of Proteome Research 10 (10):4825–34. doi:https://doi.org/10.1021/pr200629p.
- Georges, P., M. Sylvestre, H. Ruegger, and P. Bourgeois. 2006. Ketosteroids and hydroxyketosteroids, minor metabolites of sugarcane wax. Steroids 71 (8):647–52. doi:https://doi.org/10.1016/j.steroids.2006.01.016.
- Ghosh, A., and K. Nishtala. 2017. Biofluid lipidome: A source for potential diagnostic biomarkers. Clinical and Translational Medicine 6 (1):22. doi:https://doi.org/10.1186/s40169-017-0152-7.
- Grzelczyk, A., and E. Gendaszewska-Darmach. 2013. Novel bioactive glycerol-based lysophospholipids: New data - new insight into their function. Biochimie 95 (4):667–79. doi:https://doi.org/10.1016/j.biochi.2012.10.009.
- Holland, W. L., and S. A. Summers. 2008. Sphingolipids, insulin resistance, and metabolic disease: New insights from in vivo manipulation of sphingolipid metabolism. Endocrine Reviews 29 (4):381–402. doi:https://doi.org/10.1210/er.2007-0025.
- Joseph, S. B., A. Castrillo, B. A. Laffitte, D. J. Mangelsdorf, and P. Tontonoz. 2003. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nature Medicine 9 (2):213–9. doi:https://doi.org/10.1038/nm820.
- Li, Z. Z., M. Berk, T. M. Mcintyre, G. J. Gores, and A. E. Feldstein. 2008. The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology (Baltimore, Md.) 47 (5):1495–503. doi:https://doi.org/10.1002/hep.22183.
- Malhi, H., S. F. Bronk, N. W. Werneburg, and G. J. Gores. 2006. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. The Journal of Biological Chemistry 281 (17):12093–101. doi:https://doi.org/10.1074/jbc.M510660200.
- Chitturi. S., S. Abeygunasekera., GC. Farrell GC., J. Holmes-Walker., JM. Hui., C.Fung., R. Karim., R. Lin., D. Samarasinghe., C. Liddle., M. Weltman., and, J. George. 2002. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology (Baltimore, Md.) 35 (2): 373–379. doi:https://doi.org/10.1053/jhep.2002.30692.
- Neuschwander-Tetri, B. A. 2010. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites. Hepatology (Baltimore, Md.) 52 (2):774–88. doi:https://doi.org/10.1002/hep.23719.
- Neuschwander-Tetri, B. A., and S. H. Caldwell. 2010. Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology 37 (5): 1202–19. doi: https://doi.org/10.1053/jhep.2003.50193.
- Pagadala, M., T. Kasumov, A. J. Mccullough, N. N. Zein, and J. P. Kirwan. 2012. Role of ceramides in nonalcoholic fatty liver disease. Trends in Endocrinology and Metabolism: TEM 23 (8):365–71. doi:https://doi.org/10.1016/j.tem.2012.04.005.
- Puri, P.,. R. A. Baillie, M. Wiest, F. Mirshahi, and A. J. Sanyal. 2006. A lipidomic analysis of non-alcoholic fatty liver disease (NAFLD). Journal of Hepatology 44 (4):S260–S261. doi:https://doi.org/10.1016/S0168-8278(06)80708-7.
- Quehenberger, O., A. M. Armando, A. H. Brown, S. B. Milne, D. S. Myers, A. H. Merrill, S. Bandyopadhyay, K. N. Jones, S. Kelly, R. L. Shaner, et al. 2010. Lipidomics reveals a remarkable diversity of lipids in human plasma. Journal of Lipid Research 51 (11):3299–305. doi:https://doi.org/10.1194/jlr.M009449.
- Sanyal, A. J., and T. Pacana. 2015. A lipidomic readout of disease progression in a diet-induced mouse model of nonalcoholic fatty liver disease. Transactions of the American Clinical and Climatological Association 126:271–88.
- Schachter, J. B., D. S. Lester, and D. L. Alkon. 1996. Synergistic activation of protein kinase C by arachidonic acid and diacylglycerols in vitro: Generation of a stable membrane-bound, cofactor-independent state of protein kinase C activity. Biochimica et Biophysica Acta (BBA) - General Subjects 1291 (2):167–76. doi:https://doi.org/10.1016/0304-4165(96)00063-3.
- Shamseddine, A. A., M. V. Airola, and Y. A. Hannun. 2015. Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes. Advances in Biological Regulation 57:24–41. doi:https://doi.org/10.1016/j.jbior.2014.10.002.
- Summers, S. A. 2006. Ceramides in insulin resistance and lipotoxicity. Progress in Lipid Research 45 (1):42–72. doi:https://doi.org/10.1016/j.plipres.2005.11.002.
- Tippetts, T. S., W. L. Holland, and S. A. Summers. 2018. The ceramide ratio: A predictor of cardiometabolic risk. Journal of Lipid Research 59 (9):1549–50. doi:https://doi.org/10.1194/jlr.C088377.